BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 17910588)

  • 1. The involvement of the substantia nigra pars reticulata in hypoglycemic seizures.
    Velísková J; Chudomel O; Poon KL; Marshall B; Velísek L
    Epilepsia; 2007; 48 Suppl 5():106-8. PubMed ID: 17910588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in nigral NMDA and GABAA receptor control of the striatal dopamine level after repetitive exposures to nitrogen narcosis.
    Lavoute C; Weiss M; Rostain JC
    Exp Neurol; 2008 Jul; 212(1):63-70. PubMed ID: 18452916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GABA/BZ-and NMDA-receptor interaction in digoxin-induced convulsions in rats.
    Gautam SK; Kulkarni SK
    Indian J Exp Biol; 1991 Jul; 29(7):636-40. PubMed ID: 1665475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GABAergic mechanisms in regulating the activity state of substantia nigra pars reticulata neurons.
    Windels F; Kiyatkin EA
    Neuroscience; 2006 Jul; 140(4):1289-99. PubMed ID: 16713116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex-specific control of flurothyl-induced tonic-clonic seizures by the substantia nigra pars reticulata during development.
    Velísek L; Velísková J; Giorgi FS; Moshé SL
    Exp Neurol; 2006 Sep; 201(1):203-11. PubMed ID: 16730708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Convulsions induced by methylmalonic acid are associated with glutamic acid decarboxylase inhibition in rats: a role for GABA in the seizures presented by methylmalonic acidemic patients?
    Malfatti CR; Perry ML; Schweigert ID; Muller AP; Paquetti L; Rigo FK; Fighera MR; Garrido-Sanabria ER; Mello CF
    Neuroscience; 2007 Jun; 146(4):1879-87. PubMed ID: 17467181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of robust anticonvulsant effects of muscimol microinfusions in the anterior substantia nigra of kindled rats.
    Gernert M; Löscher W
    Eur J Pharmacol; 2001 Nov; 432(1):35-41. PubMed ID: 11734185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GABA(B) receptor activation inhibits dopamine D1 receptor-mediated facilitation of [(3)H]GABA release in substantia nigra pars reticulata.
    Nava-Asbell C; Paz-Bermudez F; Erlij D; Aceves J; Florán B
    Neuropharmacology; 2007 Oct; 53(5):631-7. PubMed ID: 17868750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex- and cell-type-specific patterns of GABAA receptor and estradiol-mediated signaling in the immature rat substantia nigra.
    Galanopoulou AS
    Eur J Neurosci; 2006 May; 23(9):2423-30. PubMed ID: 16706849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic environment in substantia nigra reticulata is critical for the expression and control of hypoglycemia-induced seizures.
    Velísek L; Velísková J; Chudomel O; Poon KL; Robeson K; Marshall B; Sharma A; Moshé SL
    J Neurosci; 2008 Sep; 28(38):9349-62. PubMed ID: 18799669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-dependent changes in substantia nigra GABA-mediated seizure suppression.
    Moshé SL; Sperber EF; Brown LL; Tempel A
    Epilepsy Res Suppl; 1992; 8():97-106. PubMed ID: 1329831
    [No Abstract]   [Full Text] [Related]  

  • 12. Modulation by GABA transmission in the substantia nigra compacta and reticulata of locomotor activity in rats exposed to high pressure.
    Kriem B; Cagniard B; Bouquet C; Rostain JC; Abraini JH
    Neuroreport; 1998 May; 9(7):1343-7. PubMed ID: 9631426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electrical stimulation of substantia nigra pars reticulata is anticonvulsant in adult and young male rats.
    Velísek L; Velísková J; Moshé SL
    Exp Neurol; 2002 Jan; 173(1):145-52. PubMed ID: 11771947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of oro-facio-lingual movements by the substantia nigra pars reticulata: high-frequency electrical microstimulation and GABA microinjection findings in rats.
    Inchul P; Amano N; Satoda T; Murata T; Kawagishi S; Yoshino K; Tanaka K
    Neuroscience; 2005; 134(2):677-89. PubMed ID: 15987665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the substantia nigra suppresses absences and clonic seizures in audiogenic rats, but not tonic seizures: evidence for seizure specificity of the nigral control.
    Deransart C; Lê-Pham BT; Hirsch E; Marescaux C; Depaulis A
    Neuroscience; 2001; 105(1):203-11. PubMed ID: 11483312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of synaptic GABAA receptor function by zolpidem in substantia nigra pars reticulata.
    Zhang LL; Chen L; Xue Y; Yung WH
    Acta Pharmacol Sin; 2008 Feb; 29(2):161-8. PubMed ID: 18215344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blockade of androgen receptors is sufficient to alter the sexual differentiation of the substantia nigra pars reticulata seizure-controlling network.
    Heida JG; Velísková J; Moshé SL
    Epileptic Disord; 2008 Mar; 10(1):8-12. PubMed ID: 18367425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Divergent alterations in gamma-aminobutyric acid/benzodiazepine responses of male and ovariectomized rats after chronic benzodiazepine agonist exposure: electrophysiological analysis of substantia nigra pars reticulata neurons.
    Wilson MA
    J Pharmacol Exp Ther; 1993 Aug; 266(2):774-9. PubMed ID: 8394917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis.
    Ishiwari K; Mingote S; Correa M; Trevitt JT; Carlson BB; Salamone JD
    J Neurosci Methods; 2004 Dec; 140(1-2):39-46. PubMed ID: 15589332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developmental aspects of the basal ganglia and therapeutic perspectives.
    Velísková J; Claudio OI; Galanopoulou AS; Kyrozis A; Lado FA; Ravizza T; Velísek L; Moshé SL
    Epileptic Disord; 2002 Dec; 4 Suppl 3():S73-82. PubMed ID: 12495877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.